Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

AMRX

Amneal Pharmaceuticals (AMRX)

Amneal Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AMRX
DateTimeSourceHeadlineSymbolCompany
08/03/202508:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
06/03/202512:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
06/03/202511:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
06/03/202511:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
06/03/202511:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
06/03/202511:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
06/03/202509:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
06/03/202508:57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
05/03/202510:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
28/02/202522:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMRXAmneal Pharmaceuticals Inc
28/02/202522:00Business WireAmneal Reports Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:AMRXAmneal Pharmaceuticals Inc
20/02/202500:00Business WireAmneal Launches Mesalamine and Receives U.S. FDA Approval for LenalidomideNASDAQ:AMRXAmneal Pharmaceuticals Inc
06/02/202508:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
30/01/202500:30Business WireAmneal to Report Fourth Quarter and Full Year 2024 Results on February 28, 2025NASDAQ:AMRXAmneal Pharmaceuticals Inc
24/01/202509:49Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:AMRXAmneal Pharmaceuticals Inc
24/01/202500:00Business WireAmneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for RifaximinNASDAQ:AMRXAmneal Pharmaceuticals Inc
15/01/202522:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMRXAmneal Pharmaceuticals Inc
11/01/202508:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
07/01/202508:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
03/01/202508:48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
05/12/202400:00Business WireAmneal to Participate at Upcoming Investor ConferencesNASDAQ:AMRXAmneal Pharmaceuticals Inc
27/11/202408:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
26/11/202408:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
23/11/202408:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
23/11/202402:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
22/11/202408:05Business WireAmneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 AgonistNASDAQ:AMRXAmneal Pharmaceuticals Inc
22/11/202406:01Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
20/11/202408:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
16/11/202405:49Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMRXAmneal Pharmaceuticals Inc
15/11/202408:11Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AMRXAmneal Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:AMRX

Your Recent History

Delayed Upgrade Clock